New Treatment for UTIs

The Food and Drug Administration (FDA) has approved a new oral antibiotic, Pivya (pivmecillinam), to treat women over 18 with uncomplicated UTIs, which are contained in the bladder and haven’t spread to the kidneys. Kyle Graham, M.D., a board-certified OBGYN and medical director at Obstetrics and Gynecology of San Jose, part of Pediatrix® Medical Group, said the FDA’s sign-off gives medical providers a much-needed additional treatment option for the painful infections. “Having another antibiotic available to treat UTIs helps us treat UTIs that are resistant to commonly used antibiotics,” he said. Dr. Graham explained that Pivya works “by building up the highest concentrations in the bladder and not in other organs,” which is why it’s not meant to treat complicated UTIs.

View the full story on Health